Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Virtual Reality: An Immersive Educational Experience

Jason Liebowitz, MD, FACR  |  Issue: May 2025  |  April 8, 2025

Healthcare professionals also benefit from the app because this tool provides a quick introduction to key treatment concepts. Switching a patient’s therapy—especially to a novel, data-limited modality, such as CAR T cell therapy—is a significant decision for any doctor, one that should not be taken lightly, and it benefits from patients and physicians being on the same page with regard to potential risks and benefits.

We also see value for caregivers, family members and clinical staff, with the app helping ensure that everyone involved is well informed. Lastly, students at the high school level and beyond who are interested in these medical science concepts can use the app to familiarize themselves with emerging immunological therapies in the field of rheumatology. 

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

TR: Are there other VR apps for patient education in rheumatology or medicine?

NK: We initially developed a single-player, VR version from our social VR [version], allowing individuals to navigate the experience independently. Currently, we are collaborating with experts from Universitätsklinikum Erlangen to extend our work beyond lupus, including myositis and systemic sclerosis, both of which are autoimmune conditions that have been successfully treated with CAR T therapy. [Because] many models, animations and interactions are already in place, adapting to new diseases is efficient and cost effective.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Another project focuses on rheumatoid arthritis, [for which] we are developing an interactive mobile game with augmented reality and mixed reality elements to illustrate inflammatory bone disorders. By way of background, augmented reality is a technology that superimposes a computer-generated image on a user’s view of the real world, thereby providing a composite view. Mixed reality is a medium that consists of immersive computer-generated environments in which elements of a physical and virtual space are combined.

We believe that such novel approaches will help expand the scope and utility of our applications.

‘Our personal experience reinforced the need for better patient education. … When facing a severe disease, understanding all treatment options is vital for making the best decisions.’ —Mr. Kandera

TR: What advantages does VR offer for patient education, compared with traditional methods?

NK: This therapy is new and complex, combining immunology and oncology. Understanding treatment mechanisms, risks and side effects—such as cytokine storm—requires a deep knowledge base that is challenging for doctors to convey within the usual time constraints of a busy day.

VR provides an accessible, immersive learning environment, guiding patients through the treatment process step by step. It allows doctors to explain complex topics more effectively and answer questions with the help of contextualization. Additionally, it ensures consistent, high-quality medical education, reducing misunderstandings and increasing patient confidence.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:AppsEducation & TrainingTechnology Tagged with:appsEducationpatient educationTechnologyvirtual reality

Related Articles

    CAR-T Cell Therapy in Autoimmune Disease: The Next Frontier

    July 2, 2024

    Chimeric antigen receptor (CAR) T cell therapy has the potential to fundamentally shift the treatment of autoimmune disease. During his presentation at EULAR 2024, Georg Schett, MD, provided an overview of this treatment process and described the promising findings of the latest research.

    Make Rehab Fun: Virtual Reality & Therapeutic Gaming

    December 12, 2019

    Using virtual reality in rehabilitation can have benefits—as long as it is properly understood. In fact, some evidence suggests benefits from the judicious use of immersive virtual reality with patients with rheumatic diagnoses. People tend to have a lower perception of effort compared with actual exertion and lower reports of pain with longer time to exhaustion.

    Editor's Pick

    B Cell-Depleting Therapy in SLE

    September 19, 2024

    “SLE has long been a disease with many clinical manifestations but few treatment options,” says Physician Editor Bharat Kumar, explaining why he thinks this article is a must-read. “That’s rapidly changing with advances in our knowledge of lupus, especially in the role of B-cells in triggering the onset and perpetuating disease activity of lupus.”

    CAR-T Cells: Are We Closer to Drug-Free Remission Than We Think?

    July 8, 2024

    Most Sunday mornings, I make myself an exceptional cup of pour-over coffee and sit down on my deck with the latest issue of the New England Journal of Medicine. I check out the image of the week. I read the case report with pen in hand, racing to diagnose the patient before the authors spill…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences